The Role of Postoperative Radiotherapy in Intracranial Solitary Fibrous Tumor/Hemangiopericytoma: A Multi-institutional Retrospective Study (KROG 18-11)
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: This study aimed to evaluate the role of postoperative radiotherapy (PORT) in intracranial solitary fibrous tumor/hemangiopericytoma (SFT/HPC). Materials and methods: A total of 133 patients with histologically confirmed HPC were included from eight institutions. Gross total resection (GTR) and subtotal resection (STR) were performed in 86 and 47 patients, respectively. PORT was performed in 85 patients (64%). The prognostic effects of sex, age, performance, World Health Organization (WHO) grade, location, size, Ki-67, surgical extent, and PORT on local control (LC), distant metastasis-free survival (DMFS), progression-free survival (PFS), and overall survival (OS) were estimated by univariate and multivariate analyses. Results: The 10-year PFS, and OS rates were 45%, and 71%, respectively. The multivariate analysis suggested that PORT significantly improved LC (p < 0.001) and PFS (p < 0.001). The PFS benefit of PORT was maintained in the subgroup of GTR (p=0.001), WHO grade II (p=0.001), or STR (p < 0.001). In the favorable subgroup of GTR and WHO grade II, PORT was also significantly related to better PFS (p=0.028). WHO grade III was significantly associated with poor DMFS (p=0.029). In the PORT subgroup, the 0-0.5 cm margin of the target volume showed an inferior LC to a large margin with 1.0-2.0 cm (p=0.021). Time-dependent Cox proportion analysis showed that distant failures were significantly associated with poor OS (p=0.003). Conclusion: This multicenter study supports the role of PORT in disease control of intracranial SFT/HPC, irrespective of the surgical extent and grade. For LC, PORT should enclose the tumor bed with sufficient margin.
Abstract
Purpose: This study aimed to evaluate the role of postoperative radiotherapy (PORT) in intracranial solitary fibrous tumor/hemangiopericytoma (SFT/HPC). Materials and methods: A total of 133 patients with histologically confirmed HPC were included from eight institutions. Gross total resection (GTR) and subtotal resection (STR) were performed in 86 and 47 patients, respectively. PORT was performed in 85 patients (64%). The prognostic effects of sex, age, performance, World Health Organization (WHO) grade, location, size, Ki-67, surgical extent, and PORT on local control (LC), distant metastasis-free survival (DMFS), progression-free survival (PFS), and overall survival (OS) were estimated by univariate and multivariate analyses. Results: The 10-year PFS, and OS rates were 45%, and 71%, respectively. The multivariate analysis suggested that PORT significantly improved LC (p < 0.001) and PFS (p < 0.001). The PFS benefit of PORT was maintained in the subgroup of GTR (p=0.001), WHO grade II (p=0.001), or STR (p < 0.001). In the favorable subgroup of GTR and WHO grade II, PORT was also significantly related to better PFS (p=0.028). WHO grade III was significantly associated with poor DMFS (p=0.029). In the PORT subgroup, the 0-0.5 cm margin of the target volume showed an inferior LC to a large margin with 1.0-2.0 cm (p=0.021). Time-dependent Cox proportion analysis showed that distant failures were significantly associated with poor OS (p=0.003). Conclusion: This multicenter study supports the role of PORT in disease control of intracranial SFT/HPC, irrespective of the surgical extent and grade. For LC, PORT should enclose the tumor bed with sufficient margin.
참고문헌 (30)
- Stout AP, "Hemangiopericytoma : a vascular tumor featuring Zimmermann’s pericytes", Ann Surg, 116, pp.26~33 (1942)
- 도윤식, "An Updated Nationwide Epidemiology of Primary Brain Tumors in Republic of Korea, 2013", Brain Tumor Research and Treatment, 5(1), pp.16~23 (2017), 대한뇌종양학회
- Kim JH, "Meningeal hemangiopericytomas : long-term outcome and biological behavior", Surg Neurol, 59, pp.47~53 (2003)
- Ghia AJ, "Intracranial hemangiopericytoma : patterns of failure and the role of radiation therapy", Neurosurgery, 73, pp.624~630 (2013)
- Ghia AJ, "Intracranial hemangiopericytoma and the role of radiation therapy : a population based analysis", Neurosurgery, 72, pp.203~209 (2013)
- Sonabend AM, "The role for adjuvant radiotherapy in the treatment of hemangiopericytoma : a Surveillance, Epidemiology, and End Results analysis", J Neurosurg, 120, pp.300~308 (2014)
- Vuorinen V, "Outcome of 31 intracranial haemangiopericytomas : poor predictive value of cell proliferation indices", Acta Neurochir(Wien), 138, pp.1399~1408 (1996)
- Guthrie BL, "Meningeal hemangiopericytoma : histopathological features, treatment, and long-term follow-up of 44 cases", Neurosurgery, 25, pp.514~522 (1989)
- Stessin AM, "The role of postoperative radiation therapy in the treatment of meningeal hemangiopericytoma-experience from the SEER database", Int J Radiat Oncol Biol Phys, 85, pp.784~790 (2013)
- Rutkowski MJ, "Intracranial hemangiopericytoma : clinical experience and treatment considerations in a modern series of 40 adult patients", Cancer, 118, pp.1628~1636 (2012)
- Zhu H, "Prognostic factors in patients with primary hemangiopericytomas of the central nervous system : a series of 103 cases at a single institution", World Neurosurg, 90, pp.414~419 (2016)
- Jeon SH, "Efficacy of adjuvant radiotherapy in the intracranial hemangiopericytoma", J Neurooncol, 137, pp.567~573 (2018)
- Lee EJ, "The impact of postoperative radiation therapy on patterns of failure and survival improvement in patients with intracranial hemangiopericytoma", J Neurooncol, 127, pp.181~190 (2016)
- Rutkowski MJ, "Predictors of mortality following treatment of intracranial hemangiopericytoma", J Neurosurg, 113, pp.333~339 (2010)
- Schiariti M, "Hemangiopericytoma: long-term outcome revisited. Clinical article", J Neurosurg, 114, pp.747~755 (2011)
- Sung KS, "Solitary fibrous tumor", hemangiopericytoma : treatment results based on the 2016 WHO classification, 2019, pp.130, 418~425
- Melone AG, "Intracranial hemangiopericytoma : our experience in 30 years : a series of 43 cases and review of the literature", World Neurosurg, 81, pp.556~562 (2014)
- Kano H, "Adjuvant stereotactic radiosurgery after resection of intracranial hemangiopericytomas", Int J Radiat Oncol Biol Phys, 72, pp.1333~1339 (2008)
- Olson C, "Radiosurgery for intracranial hemangiopericytomas : outcomes after initial and repeat Gamma Knife surgery", J Neurosurg, 112, pp.133~139 (2010)
- Copeland WR, "Single-fraction stereotactic radiosurgery of meningeal hemangiopericytomas", J Neurooncol, 120, pp.95~102 (2014)
- Kim JW, "Gamma Knife stereotactic radiosurgery for intracranial hemangiopericytomas", J Neurooncol, 99, pp.115~122 (2010)
- Kano H, "Stereotactic radiosurgery for intracranial hemangioblastomas : a retrospective international outcome study", J Neurosurg, 122, pp.1469~1478 (2015)
- Cohen-Inbar O, "Stereotactic radiosurgery for intracranial hemangiopericytomas : a multicenter study", J Neurosurg, 126, pp.744~754 (2017)
- Martin-Broto J, "Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour : a multicentre, single-arm, phase 2 trial", Lancet Oncol, 20, pp.134~144 (2019)
- Soyuer S, "Intracranial meningeal hemangiopericytoma : the role of radiotherapy : report of 29 cases and review of the literature", Cancer, 100, pp.1491~1497 (2004)
- Fountas KN, "Management of intracranial meningeal hemangiopericytomas : outcome and experience", Neurosurg Rev, 29, pp.145~153 (2006)
- Park MS, "Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor", Cancer, 117, pp.4939~4947 (2011)
- Schweizer L, "Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein", Acta Neuropathol, 125, pp.651~658 (2013)
- Robinson DR, "Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing", Nat Genet, 45, pp.180~185 (2013)
- Ciliberti MP, "The radiation therapy options of intracranial hemangiopericytoma : an overview and update on a rare vascular mesenchymal tumor", Oncol Rev, 12, pp.354~ (2018)